What Is Insmed Incorporated (INSM) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Insmed Incorporated's intrinsic value is estimated at $54.95, suggesting the stock is overvalued at its current price of $109.81. With 10 out of 12 models flagging downside (-50.0% average return), the market may be pricing in unsustainable growth. Model dispersion is worth noting: First Chicago targets $168.76 (+53.7%), versus Dynamic NAV at $2.52 (-97.7%). This +151.4% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About INSM?
12 of 13 models are currently active for INSM. Of these, 2 models suggest upside while 10 models suggest overvaluation. The Bayesian DCF estimates INSM's intrinsic value at $32.60, implying -70.3% downside from the current price. See which stocks rank higher →
How Does INSM Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, INSM ranks #331 by Quality of Company score. CirclFi's QOC score of 4.0/10 evaluates 32 fundamental signals. A score of 4.0 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a biopharma enterprise, Insmed Incorporated operates in a sector where FDA approval probability is a critical driver of valuation. Investors evaluating INSM should weigh these sector-specific dynamics alongside our model-derived fair values.
Is INSM a Value Trap?
CirclFi's Value Trap algorithm assigns INSM a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Insmed Incorporated. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Insmed Incorporated's fundamental quality profile registers 4.0/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +151.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every INSM valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across INSM's 12 active models, average confidence is 29%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad